# Type B Aortic Dissection Quality Control Platform

> **NCT07745309** · — · NOT_YET_RECRUITING · sponsor: **Chang Shu** · enrollment: 2375 (estimated)

## Conditions studied

- Endovascular Surgery
- Medical Quality
- Prognostic Early Warning
- Stanford Type B Aortic Dissection

## Interventions

- **PROCEDURE:** Endo vascular repair

## Key facts

- **NCT ID:** NCT07745309
- **Lead sponsor:** Chang Shu
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-09
- **Final completion:** 2029-08
- **Target enrollment:** 2375 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745309, "Type B Aortic Dissection Quality Control Platform". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07745309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*